Marshall Wace North America’s PLDT PHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$289K Sell
8,892
-30,507
-77% -$827K ﹤0.01% 1256
2021
Q2
$1.03M Buy
39,399
+21,882
+125% +$582K ﹤0.01% 1001
2021
Q1
$458K Buy
+17,517
New +$490K ﹤0.01% 1222
2020
Q4
Sell
-15,000
Closed -$405K 1511
2020
Q3
$405K Buy
15,000
+5,985
+66% +$167K ﹤0.01% 1012
2020
Q2
$220K Sell
9,015
-11,941
-57% -$284K ﹤0.01% 1061
2020
Q1
$432K Buy
20,956
+8,890
+74% +$176K ﹤0.01% 786
2019
Q4
$242K Sell
12,066
-22,253
-65% -$466K ﹤0.01% 933
2019
Q3
$755K Sell
34,319
-23,235
-40% -$519K ﹤0.01% 744
2019
Q2
$1.43M Sell
57,554
-7,193
-11% -$171K 0.01% 651
2019
Q1
$1.4M Buy
64,747
+61,647
+1,989% +$1.39M 0.01% 604
2018
Q4
$66K Buy
+3,100
New +$73.2K ﹤0.01% 1181

Other funds holding PHI

Marshall Wace North America's PHI Position: Q3 2021 in Review

Marshall Wace North America reduced its PLDT (PHI) stake by 77% in Q3 2021, selling an estimated $827K and leaving 8,892 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Marshall Wace North America first reported a position in PHI in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.43M in Q2 2019. 71 funds tracked by Wall St. Rank hold PHI as of Q3 2021.

  • Marshall Wace North America held 8,892 shares of PLDT worth $289K as of Q3 2021.
  • Marshall Wace North America sold 30,507 PLDT shares in Q3 2021, an estimated $827K.
  • PLDT made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1256 holding.
  • Marshall Wace North America first reported a position in PLDT in Q4 2018 and has held it in 11 quarters since.
  • Marshall Wace North America's PLDT position peaked at $1.43M in Q2 2019.
  • 71 funds tracked by Wall St. Rank held PLDT as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.